Breast cancer multigene testing trends and impact on chemotherapy use. - Test2 - elhamkhani - TriplyDB

Breast cancer multigene testing trends and impact on chemotherapy use.

Breast cancer multigene testing trends and impact on chemotherapy use.

http://www.wikidata.org/entity/Q37083264

about

Oncologist and organizational factors associated with variation in breast cancer multigene testing.Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.Cost Effectiveness of Gene Expression Profile Testing in Community Practice.

P2860

Q38948829-90FE3ACD-8E85-498F-BE82-DA62D45AFA8E Q39254713-FD4AE534-1605-4FB1-9749-C74E5D2DA80C Q47198620-D8E32E4E-0F2A-4BFE-9C49-76B4B0350884

P2860

Breast cancer multigene testing trends and impact on chemotherapy use.

http://www.wikidata.org/entity/Q37083264

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Breast cancer multigene testing trends and impact on chemotherapy use.

@en

Breast cancer multigene testing trends and impact on chemotherapy use.

@nl

type

label

Breast cancer multigene testing trends and impact on chemotherapy use.

@en

Breast cancer multigene testing trends and impact on chemotherapy use.

@nl

prefLabel

Breast cancer multigene testing trends and impact on chemotherapy use.

@en

Breast cancer multigene testing trends and impact on chemotherapy use.

@nl

P1433

Q37083264-47B40729-2390-449D-9DDD-95485A34168A

P1476

Q37083264-957A62B8-B9A6-4F7F-BB0A-A35587A5D0B6

P2093

Q37083264-0B6B2E66-017E-440B-AF78-469B5DDF1C39

Q37083264-41FC4F59-337C-44EA-94E9-176D29DC50EA

Q37083264-5C4F30C5-586B-49BB-B600-73E6B07DD122

Q37083264-96462A49-6774-4DB5-9140-C0B933992505

Q37083264-AF7E3269-06DF-4EA4-A2DD-4A1867FA4BC9

Q37083264-E62A8AD1-B86C-492B-90E1-6777811CE5B8

Q37083264-ED12F9AD-CBDB-469E-A984-D25149E014E7

P2860

Q37083264-131F3CA7-6B7B-42E2-AACC-2080CE89F18E

Q37083264-185EE0E6-EF59-48EB-81A5-14DF1D081A06

Q37083264-1BC2DA7D-35CC-4494-8E91-84E1F1804BC1

Q37083264-303FA0E6-C5E7-49DC-8B14-AD3754C7157A

Q37083264-36BE3314-0090-4F7C-BDE0-642A17068AD0

Q37083264-36C5914F-2E20-4A84-845F-9456B97FE33A

Q37083264-4135BFAE-435E-473F-8CD9-836644391E91

Q37083264-528CB9E0-8871-4731-B51D-F294B5584B2D

Q37083264-694DC846-717B-4655-873C-D94A552C8522

Q37083264-73578451-4FEC-499E-996A-98E63C1E7DF1

P304

Q37083264-F836C51C-1157-4C17-9F17-7B4A5F22DA09

P31

Q37083264-7AEA7CF6-B0EB-4A86-B3EE-20E9C76424EF

P433

Q37083264-92658095-4B4E-4771-BC35-48EFD8EBF542

P478

Q37083264-4194081F-5929-41D0-899C-BE5FB9EB5158

P577

Q37083264-F1B4091B-287C-4F78-8730-DB9381F4BB8B

P698

Q37083264-93A49537-D91E-4B6D-8EDA-900AB985CA9A

P921

Q37083264-86D5C9FD-C779-4717-9170-E23970035604

P932

Q37083264-38AF69DE-94D4-47E0-A056-56A4B1514AB5

P1433

The American journal of managed care

P1476

Breast cancer multigene testing trends and impact on chemotherapy use.

@en

P2093

G Thomas Ray

http://www.w3.org/2001/XMLSchema#string

Jeanne Mandelblatt

http://www.w3.org/2001/XMLSchema#string

Laurel A Habel

http://www.w3.org/2001/XMLSchema#string

Lawrence H Kushi

http://www.w3.org/2001/XMLSchema#string

Scott Ramsey

http://www.w3.org/2001/XMLSchema#string

Tracy A Lieu

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

A new initiative on precision medicine

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

P304

e153-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27266581

http://www.w3.org/2001/XMLSchema#string

P921

P932

4940166

http://www.w3.org/2001/XMLSchema#string